These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 24876717)

  • 1. Prognostic factors for hepatocellular carcinoma recurrence.
    Colecchia A; Schiumerini R; Cucchetti A; Cescon M; Taddia M; Marasco G; Festi D
    World J Gastroenterol; 2014 May; 20(20):5935-50. PubMed ID: 24876717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection: an analysis of 610 patients over 16 years old.
    Taura K; Ikai I; Hatano E; Fujii H; Uyama N; Shimahara Y
    Ann Surg; 2006 Aug; 244(2):265-73. PubMed ID: 16858190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.
    Majumdar A; Roccarina D; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011650. PubMed ID: 28351116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods.
    Kuo MJ; Mo LR; Chen CL
    BMC Cancer; 2021 Mar; 21(1):250. PubMed ID: 33685409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances of radiofrequency ablation for early hepatocellular carcinoma.
    Izumi N
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():115-22. PubMed ID: 21199522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of hepatocellular carcinoma in the cirrhotic liver].
    Hourmand-Ollivier I; Chiche L
    J Chir (Paris); 2004 Mar; 141(2):71-83. PubMed ID: 15133430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation.
    Lao OB; Weissman J; Perkins JD
    Clin Transplant; 2009; 23(6):874-81. PubMed ID: 19453644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early intrahepatic recurrence of hepatocellular carcinoma after hepatectomy treated with re-hepatectomy, ablation or chemoembolization: a prospective cohort study.
    Wang K; Liu G; Li J; Yan Z; Xia Y; Wan X; Ji Y; Lau WY; Wu M; Shen F
    Eur J Surg Oncol; 2015 Feb; 41(2):236-42. PubMed ID: 25434327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion.
    Jin YJ; Lee JW; Lee OH; Chung HJ; Kim YS; Lee JI; Cho SG; Jeon YS; Lee KY; Ahn SI; Shin WY
    J Gastroenterol Hepatol; 2014 May; 29(5):1056-64. PubMed ID: 24372785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma.
    Koda M; Murawaki Y; Mitsuda A; Ohyama K; Horie Y; Suou T; Kawasaki H; Ikawa S
    Cancer; 2000 Feb; 88(3):529-37. PubMed ID: 10649243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma.
    Weis S; Franke A; Mössner J; Jakobsen JC; Schoppmeyer K
    Cochrane Database Syst Rev; 2013 Dec; (12):CD003046. PubMed ID: 24357457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethanol injection is highly effective for hepatocellular carcinoma smaller than 2 cm.
    Pompili M; Nicolardi E; Abbate V; Miele L; Riccardi L; Covino M; De Matthaeis N; Grieco A; Landolfi R; Rapaccini GL
    World J Gastroenterol; 2011 Jul; 17(26):3126-32. PubMed ID: 21912455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival in patients with recurrent hepatocellular carcinoma after primary hepatectomy: comparative effectiveness of treatment modalities.
    Ho CM; Lee PH; Shau WY; Ho MC; Wu YM; Hu RH
    Surgery; 2012 May; 151(5):700-9. PubMed ID: 22284764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver stiffness measured by MR elastography is a predictor of early HCC recurrence after treatment.
    Cho HJ; Kim B; Kim HJ; Huh J; Kim JK; Lee JH; Seo CW; Ahn HR; Eun JW; Kim SS; Cho SW; Cheong JY
    Eur Radiol; 2020 Aug; 30(8):4182-4192. PubMed ID: 32189053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prognostic model and treatment strategy for intrahepatic recurrence of hepatocellular carcinoma after curative resection.
    Umeda Y; Matsuda H; Sadamori H; Matsukawa H; Yagi T; Fujiwara T
    World J Surg; 2011 Jan; 35(1):170-7. PubMed ID: 20922387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appropriate treatment strategies for intrahepatic recurrence after curative resection of hepatocellular carcinoma initially within the Milan criteria: according to the recurrence pattern.
    Zhang X; Li C; Wen T; Yan L; Li B; Yang J; Wang W; Xu M; Lu W; Jiang L
    Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):933-40. PubMed ID: 25933127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival analysis of patients with transplantable recurrent hepatocellular carcinoma: implications for salvage liver transplant.
    Ng KK; Lo CM; Liu CL; Poon RT; Chan SC; Fan ST
    Arch Surg; 2008 Jan; 143(1):68-74; discussion 74. PubMed ID: 18209155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors and optimal treatment strategy for intrahepatic nodular recurrence after curative resection of hepatocellular carcinoma.
    Choi GH; Kim DH; Kang CM; Kim KS; Choi JS; Lee WJ; Kim BR
    Ann Surg Oncol; 2008 Feb; 15(2):618-29. PubMed ID: 18004628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
    Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
    Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current management of hepatocellular carcinoma.
    Mendizabal M; Reddy KR
    Med Clin North Am; 2009 Jul; 93(4):885-900, viii. PubMed ID: 19577120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.